3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Breast
3
Dermatologic
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
3
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphatic Metastasis
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Squamous Cell
1
Anus Neoplasms
1
Interventions
Cyclophosphamide
423
Trastuzumab
414
Paclitaxel
375
Docetaxel
314
Capecitabine
266
Letrozole
262
Carboplatin
257
Doxorubicin
213
Tamoxifen
184
Fulvestrant
176
Epirubicin
176
Radiotherapy
171
Anastrozole
164
pembrolizumab
152
pertuzumab
147
Surveys and Questionnaires
146
Exercise
142
exemestane
128
Vinorelbine
127
palbociclib
124
Bevacizumab
123
Magnetic Resonance Spectroscopy
120
Blood Specimen Collection
120
Drug Therapy
106
Albumin-Bound Paclitaxel
105
Gemcitabine
99
130-nm albumin-bound paclitaxel
98
pyrotinib
92
eribulin
90
Biopsy
88
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Technetium-99
×
Breast
×
Clear all
NCT07146295
2026-01-12
INFINITE
St. Antonius Hospital
Phase NA
Recruiting
1,760 enrolled
NCT06378944
2024-09-19
INSEAN
Omphis Foundation
Recruiting
15,000 enrolled
NCT02997553
2023-01-09
GASVERT
Institut de Cancérologie de Lorraine
Phase 3
Completed
744 enrolled